- Home
- ISPC vs PMCB Comparison
ISPC vs PMCB Comparison
Compare ISPC & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- PMCB
- Stock Information
- Founded
- ISPC 2009
- PMCB 1996
- Country
- ISPC United States
- PMCB United States
- Employees
- ISPC 24
- PMCB N/A
- Industry
- ISPC Precision Instruments
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPC Health Care
- PMCB Health Care
- Exchange
- ISPC Nasdaq
- PMCB Nasdaq
- Market Cap
- ISPC 5.7M
- PMCB 6.6M
- IPO Year
- ISPC 2021
- PMCB N/A
- Fundamental
- Price
- ISPC $0.54
- PMCB $0.80
- Analyst Decision
- ISPC
- PMCB
- Analyst Count
- ISPC 0
- PMCB 0
- Target Price
- ISPC N/A
- PMCB N/A
- AVG Volume (30 Days)
- ISPC 216.8K
- PMCB 42.8K
- Earning Date
- ISPC 11-17-2025
- PMCB 12-12-2025
- Dividend Yield
- ISPC N/A
- PMCB N/A
- EPS Growth
- ISPC N/A
- PMCB N/A
- EPS
- ISPC N/A
- PMCB 0.01
- Revenue
- ISPC $3,352,744.00
- PMCB N/A
- Revenue This Year
- ISPC $35.93
- PMCB N/A
- Revenue Next Year
- ISPC N/A
- PMCB N/A
- P/E Ratio
- ISPC N/A
- PMCB $115.20
- Revenue Growth
- ISPC N/A
- PMCB N/A
- 52 Week Low
- ISPC $0.53
- PMCB $0.70
- 52 Week High
- ISPC $4.90
- PMCB $1.93
- Technical
- Relative Strength Index (RSI)
- ISPC 31.72
- PMCB 31.75
- Support Level
- ISPC $0.56
- PMCB $0.70
- Resistance Level
- ISPC $0.67
- PMCB $0.93
- Average True Range (ATR)
- ISPC 0.06
- PMCB 0.07
- MACD
- ISPC 0.00
- PMCB -0.01
- Stochastic Oscillator
- ISPC 16.94
- PMCB 27.07
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.